Peraso's third quarter was a revenue trough. The company reported a loss of $0.18 per share on revenue of $0.28 million, missing the $0.63 million consensus by 54.9%. Revenue fell 91.2% year over year, and earnings declined 5.9% as the loss widened from $0.17 a year ago. There was no published EPS consensus. The headline numbers are poor, but the key development came after quarter-end: a roughly $10 million private placement from Nant Capital and a production order of more than $2 million for fixed wireless access (FWA). Together they changed the company's survival math more than its operating story. That is the central tension. The balance sheet is repaired for now, but the revenue base that has to justify it has nearly disappeared.
The quality of the quarter deserves scrutiny, starting with gross margin. The 78.5% figure was up from 63.7% in Q2 and 56.2% a year ago, and it extended a four-quarter climb from 52.2% in Q4 FY25. On $284,000 of revenue, though, that percentage says little about operating leverage. A one-time inventory accrual reversal of about $55,000 accounted for roughly a quarter of the $223,000 in gross profit. What matters is that gross profit could not come close to covering $2.9 million of GAAP operating expenses. The operating loss more than doubled year over year to $2.7 million. Adjusted EBITDA worsened to negative $2.4 million from negative $2.0 million in Q2 and negative $1.0 million a year earlier. Management trimmed non-GAAP opex to $2.7 million from $2.9 million, but cost discipline cannot offset a 77% sequential revenue drop.
The balance sheet shows how close to the edge Peraso was running. Cash ended September at $630,000, down from $3.3 million at the end of Q2. Meanwhile, inventory rose to $1.95 million from $1.17 million at year-end. The Nant funding, plus about $1 million of post-quarter draws on the Roth equity facility, removed the immediate liquidity overhang. The board then ended its strategic alternatives review, which had run since late 2025. The cost is substantial dilution. Shares outstanding are now about 20.9 million, up from roughly 15.1 million at the Q2 call and 12.6 million two quarters before that. Nant also gains a significant ownership position and board designation rights. At the recent burn rate, $10 million buys perhaps a year of runway rather than permanent security.
On the call, management's posture shifted from Q2's limited visibility to a qualitative call for sequential revenue growth in Q4. The October FWA order is the most concrete support for that call. It is the largest in six quarters, but it ships through mid-2027, so it will not all land in Q4. Growth off a $0.3 million base is also a low bar. Management acknowledged that FWA normalization will take at least several quarters and that memory and component constraints persist.
The defense and edge-AI pipeline is still largely prospective:
- The PRM2145 jam-resistant UAV module was showcased at a UAV conference.
- Ground-based ad hoc defense networks are described as in late-stage evaluations.
- A humanoid-robot connectivity demo took place in October.
Bears have legitimate ammunition in what went unsaid. Several items highlighted on the Q2 call were not reiterated: Q4 ground-defense shipments, continued volume from IFF lead customer Intact, large India and Middle East FWA opportunities, and drone production timing in 2027. The finance function is also in transition. The release lists the CEO as interim CFO, while the call referenced an incoming interim CFO, Kevin Liu. No analysts asked questions, so none of this was tested publicly.
Investor sentiment improved meaningfully, rising from -0.67 to -0.48 ahead of the report, but it remains firmly negative. Price action has been harsh. Shares closed at $0.38 on November 11, down 46.6% from the $0.72 open after the August report. The stock sits about 52.5% below its 200-day moving average of $0.81. It set a 52-week low of $0.32 on October 29, around when the Nant financing closed, and has bounced roughly 20% from there while trading near the bottom of its inter-earnings range. A sub-$1 share price also keeps Nasdaq listing compliance on the risk list, as the release itself acknowledges. The Earnings Whispers trend signals remain mostly negative, with price, sequential growth, and AVWAP all still pointing down.
The bottom line is that Peraso traded an existential financing question for an execution question. The Nant capital and the $2 million-plus FWA order make a Q4 rebound plausible. Still, a 91% revenue collapse, a widening EBITDA loss, heavy dilution, and several dropped talking points from Q2 mean the recovery thesis now rests almost entirely on promises the company has not yet converted into revenue. Investors will need to see that order ship and at least one defense evaluation turn into a purchase order before the improved sentiment has a fundamental foundation.